Next Article in Journal
Functional Assessments of Gynecologic Cancer Models Highlight Differences Between Single-Node Inhibitors of the PI3K/AKT/mTOR Pathway and a Pan-PI3K/mTOR Inhibitor, Gedatolisib
Next Article in Special Issue
In Silico Design of Peptide Inhibitors Targeting HER2 for Lung Cancer Therapy
Previous Article in Journal
The Impact of FDA-Approved Novel Agents for Steroid-Refractory Chronic Graft vs. Host Disease on Treatment Patterns and Outcomes—A Single-Center Longitudinal Cohort Analysis
 
 
Editorial

Article Versions Notes

Cancers 2024, 16(20), 3522; https://doi.org/10.3390/cancers16203522
Action Date Notes Link
article pdf uploaded. 17 October 2024 17:55 CEST Version of Record https://www.mdpi.com/2072-6694/16/20/3522/pdf-vor
article xml file uploaded 18 October 2024 04:44 CEST Original file -
article xml uploaded. 18 October 2024 04:44 CEST Update https://www.mdpi.com/2072-6694/16/20/3522/xml
article pdf uploaded. 18 October 2024 04:44 CEST Updated version of record https://www.mdpi.com/2072-6694/16/20/3522/pdf
article html file updated 18 October 2024 04:46 CEST Original file https://www.mdpi.com/2072-6694/16/20/3522/html
Back to TopTop